ProfileGDS4132 / 203763_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 29% 27% 30% 35% 32% 24% 26% 31% 40% 31% 37% 42% 43% 47% 36% 47% 39% 59% 40% 44% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10169.97929
GSM201543Muscle PCOS pioglitazone 12155.646627
GSM201544Muscle PCOS pioglitazone 16177.434130
GSM201545Muscle PCOS pioglitazone 20195.549635
GSM201829Muscle PCOS pioglitazone 23186.078232
GSM201830Muscle PCOS pioglitazon 25157.718624
GSM201831Muscle PCOS pioglitazone 27160.393226
GSM201832Muscle PCOS pioglitazone 3176.883531
GSM201833Muscle PCOS pioglitazone 4197.500540
GSM201834Muscle PCOS pioglitazone 8173.268431
GSM201835Muscle PCOS after pioglitazone 10279.521837
GSM201836Muscle PCOS after pioglitazone 12297.941642
GSM201837Muscle PCOS after pioglitazone 16296.096643
GSM201838Muscle PCOS after pioglitazone 202114.50547
GSM201839Muscle PCOS after pioglitazone 23283.96436
GSM201840Muscle PCOS after pioglitazone 252119.07947
GSM201841Muscle PCOS after pioglitazone 27284.425339
GSM201842Muscle PCOS after pioglitazone 32139.06559
GSM201843Muscle PCOS after pioglitazone 42100.55240
GSM201844Muscle PCOS after pioglitazone 82111.72844